SEC Form 4 · accession 0001365618-15-000002
Anacor Pharmaceuticals, Inc. · ANAC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Anders D Hove
Director
Period of report
Nov 3, 2015
Accepted (ET)
Nov 5, 2015 · 5:59 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001411158
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Nov 3, 2015 | J | 1,500,000 | $0.00 | D | 1,225,535 | I | By Funds and LLC's |
| Common StockF3,F2 | Nov 3, 2015 | J | 372,982 | $0.00 | A | 1,598,517 | I | By Funds and LLC's |
| Common StockF4 | holding | — | — | — | 794 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On November 3, 2015, Venrock Associates IV, L.P. ("VA4"), Venrock Partners, L.P. ("VP"), Venrock Entrepreneurs Fund IV, L.P. ("VEF4"), Venrock Healthcare Capital Partners, L.P. ("VHCP") and VHCP Co-Investment Holdings, LLC ("VHCP Co-Invest") (collectively, the "Venrock Funds") distributed an aggregate of 1,500,000 shares of the common stock of the Issuer to their respective partners pro rata based on their respective interests in the Venrock Funds (the "Distribution").
- F2Following the Distribution, the Venrock Funds' shares are held as follows: 566,247 shares held by VA4, 115,475 shares held by VP, 13,913 shares held by VEF4, 447,957 shares held by VHCP and 81,943 shares held by VHCP Co-Invest. Venrock Management IV, LLC ("VM4"), Venrock Partners Management, LLC ("VPM") and VEF Management IV, LLC ("VEFM4") are the sole general partners of VA4, VP and VEF4, respectively, and may be deemed to beneficially own these shares. VHCP Management, LLC ("VHCP Management") is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. Anders Hove is a member of VM4, VPM and VEFM4 and a managing member of VHCP Management. Dr. Hove expressly disclaims beneficial ownership over all shares held by VA4, VP, VEF4, VHCP, VHCP Co-Invest, VM4, VPM, VEFM4 and VHCP Management except to the extent of his indirect pecuniary interest therein.
- F3In the Distribution, VM4 received 180,193 shares, VPM received 36,797 shares, VEFM4 received 3,502 shares, and VHCP Management received 152,490 shares. Dr. Hove is a member of VM4, VPM and VEFM4 and a managing member of VHCP Management. Dr. Hove expressly disclaims beneficial ownership over all shares held by VM4, VPM, VEFM4 and VHCP Management except to the extent of his indirect pecuniary interest therein. For VM4, VPM, VEFM4 and VHCP Management, this represents a change in form of ownership from indirect to direct but does not represent a change in beneficial ownership.
- F4The reporting person is a member of VR Management, LLC (the "Management Company"). Under an agreement between the reporting person and the Management Company, the reporting person is deemed to hold the reported securities for the sole benefit of the Management Company. The Management Company may be deemed the indirect beneficial owner of the reported securities, and the reporting person may be deemed the indirect beneficial owner of the reported securities through his interest in the Management Company. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.